Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Lucas Zarling

Concepts (62)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Lucas Zarling's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Lucas Zarling has written about over time.
Anilides, 1 publications between 2020 and 2020, average publication date February 2020. Carcinoma, Renal Cell, 1 publications between 2020 and 2020, average publication date February 2020. Cysts, 1 publications between 2020 and 2020, average publication date February 2020. Indazoles, 1 publications between 2020 and 2020, average publication date February 2020. Kidney Neoplasms, 1 publications between 2020 and 2020, average publication date February 2020. Liver Diseases, 1 publications between 2020 and 2020, average publication date February 2020. Disease-Free Survival, 1 publications between 2022 and 2022, average publication date April 2022. Transplantation, Homologous, 1 publications between 2022 and 2022, average publication date April 2022. Hematopoietic Stem Cell Transplantation, 3 publications between 2022 and 2023, average publication date July 2022. Leukemia, Myeloid, Acute, 3 publications between 2022 and 2023, average publication date July 2022. Transplantation Conditioning, 3 publications between 2022 and 2023, average publication date July 2022. Recurrence, 2 publications between 2022 and 2023, average publication date August 2022. Retrospective Studies, 4 publications between 2022 and 2023, average publication date October 2022. Antineoplastic Combined Chemotherapy Protocols, 2 publications between 2023 and 2023, average publication date June 2023. Cyclophosphamide, 2 publications between 2023 and 2023, average publication date June 2023. Doxorubicin, 2 publications between 2023 and 2023, average publication date June 2023. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 2 publications between 2023 and 2023, average publication date June 2023. Vincristine, 2 publications between 2023 and 2023, average publication date June 2023. Dexamethasone, 1 publications between 2023 and 2023, average publication date September 2023. Organoids, 1 publications between 2025 and 2025, average publication date April 2025.

To see the data from this visualization as text, click here.
Zarling's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)